Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q1 FY2023 Earnings Presentation
31 slides from Krishna Institute Of Medical Sciences's earnings presentation, Aug 10, 2022
Slide 1: KIMS Hospitals – Investor Presentation cover letter
4 KIMS HOSPITALS™ 10" August, 2022 The General Manager, The Manager, Department of Corporate services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 40
Slide 2: Making Quality Healthcare Accessible & Affordable
MAKING QUALITY HEALTHCARE ACCESSIBLE & AFFORDABLE Private & Confidential
Slide 3: Driven by a Vision
DRIVEN BY A VISION Affordable Quality Care Best-in-Class Facilities Patient Centric Systems & Processes S NT VISION: TIE PA To be the most preferred Clinical Outcome Driven Excellence R S healthcare services C TO Latest Medical Technology D O brand by providing Strong Academics & Research Oriented a
Slide 4: Multi Specialty Care
MULTI SPECIALTY CARE Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 5: KIMS Geographic Presence
KIMS GEOGRAPHIC PRESENCE Telangana Map Andhra Pradesh Map Hyderabad Map Kondapur Srikakulam Secunderabad Vizag Rajahmundry Paradise Circle Kurnool Karimnagar Gachibowli Ongole Hyderabad Nellore Anantapur Map not to scale • BEDS (3,600+) • DOCTORS (1,300+) • NURSES (3,500+) • PARAMEDICS (1,800+ ) • A
Slide 6: Dr. B. Bhaskar Rao - Visionary Behind KIMS
DR. B. BHASKAR RAO - VISIONARY BEHIND KIMS Managing Director A legend in CT Surgery, Dr. Bollineni Bhaskar Rao {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio- Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25 years. Well known i
Slide 7: Dr. Abhinay Bollineni
DR. ABHINAY BOLLINENI Chief Executive Officer Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. In a short span of 5 years, KIMS expanded and opened five additional units (
Slide 8: Board of Directors
BOARD OF DIRECTORS Mr. Rajeswara Rao G Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Shantanu Rastogi Independent Director, Managing Director Chief Executive Officer Whole-time Director Non-Executive Director Chairman (Stakeholders’ Relationship Committee) Mr. Saumen Chakrab
Slide 9: Shareholding Pattern - 30 June, 2022
SHAREHOLDING PATTERN - 30 TH JUNE, 2022 Retail, 3.3% As on 30th June 2022 Retail Pre IPO, Top Shareholders - DII / FII 9.0% Share Holder No of Shares Share Holding % Category Clearing Promoter & Promoter Members, Promoter 31,086,304 38.84% Group, 38.8% 0.0% General Atlantica 13,796,898 17.24% ICICI
Slide 10: Modern Medical Technology
MODERN MEDICAL TECHNOLOGY 4-Arm HD da Vinci O-Arm Scanner Spy Glass Robotic Surgical Multi-dimensional surgical State of the art add on to System imaging platform optimized ERCP that allows doctors to Facilitates complex for use in spine, orthopaedic, observe patients’ biliary duct surgeries that ar
Slide 11: Many Firsts...
MANY FIRSTS... • First in Asia in to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Lar
Slide 12: Key Accomplishments
KEY ACCOMPLISHMENTS Pharmacie De Qualite (PDQ) ‘Best Patient Friendly Hospital’ ‘Best Hospital to Work For’ Certification Overall PDQ Evaluation Ranked No. 1 Hospital AHPI Health Care Excellence AHPI Global Conclave Performance Score - 98% by Times of India, Hyderabad Award (2017) Award (2019) Gradi
Slide 13: Awards and Accolades
AWARDS AND ACCOLADES 2016 2017 2019 Neurology Department at KIMS Secunderabad KIMS Sec. Best Super-Specialty KIMS Secunderabad Best Hospital of the Year Hospital in Telangana ranked 3rd in India Times Healthcare National Quality Neurology India General Achievers Awards Excellence Awards 2021 2020 Ra
Slide 14: Consistent Performer Over 2 Decades
CONSISTENT PERFORMER OVER 2 DECADES (Rupees in Millions) 5,217*** 16,711 7% 11,287 7% 27. 32. R : R : A G G C C A 2,412 5,008 1,312 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022** Q1-2023 2005 2010 2015 2020 2022 Q1-2023 No. of No. of No. of No. of No. of No. of Hospitals: 1 Hospitals: 1 Hospi
Slide 15: Financial & Operational Highlights
FINANCIAL & OPERATIONAL HIGHLIGHTS FINANCIAL Q1 FY 23 Consolidated HIGHLIGHTS • From 1st April’22, “Sunshine Hospitals” has become a subsidiary of “KIMS Hospitals”, post completion of the acquisition of a 51.07% stake. • Sunshine acquisition has consolidated KIMS hospital’s position in the existing
Slide 16: Digital & ESG Initiatives
DIGITAL & ESG INITIATIVES DIGITAL During the quarter, steady progress was made on digital transformation with notable initiatives as below: INITIATIVES • We successfully launched the Docs App - An integrated app for doctors to manage patient progress and give real time feedback to the on ground team
Slide 17: Group Operating Performance - 1/3
GROUP OPERATING PERFORMANCE - 1/3 IP VOLUME OP VOLUME 136,731 21.7% 1,013,759 19.9% 116,592 39,673 324,797 830,211 31,709 32,588 SS: 5,557 270,897 SS: 49,662 182,499 KIMS: 275,135 KIMS: 34,116 FY21 FY22 Q1 FY22 Q4 FY22 Q1 FY23 FY21 FY22 Q1 FY22 Q4 FY22 Q1 FY23 OCCUPANCY* ARPOB 20.1% 84.8% 30,192 78.
Slide 18: Group Operating Performance - 2/3
GROUP OPERATING PERFORMANCE - 2/3 TOTAL REVENUE EBITDA* 16,711 5,217 13,401 31.6% 4,775 5,008 9.2% 3,672 1,428 1,312 3,805 SS: 1,110 1,202 SS: 194 KIMS: 3,898 KIMS: 1,118 FY21 FY22 Q1 FY22 Q4 FY22 Q1 FY23 FY21 FY22** Q1 FY22 Q4 FY22*** Q1 FY23 PBT PAT 4,569 3,438 1,245 0.5% -4.9% 1,074 920 1,068 833
Slide 19: Group Operating Performance - 3/3
GROUP OPERATING PERFORMANCE - 3/3 FY21 FY22 Q1 FY23 Particulars KIMS KIMS KIMS SS Group Bed Capacity 3,064 3,064 3,064 602 3,666 Operational Beds 2,590 2,590 2,620 602 3,222 Census Beds 2,246 2,246 2,276 484 2,760 Non Census Beds 344 344 344 118 462 Occupied Beds 1,765 1,793 1,616 191 1,807 Occupanc
Slide 20: Comparison of Telangana, AP Mature, Acquired & Sunshine Hospitals
COMPARISON OF TELANGANA, ANDHRA PRADESH MATURE, ACQUIRED & SUNSHINE HOSPITALS Telangana (KIMS Matured Assets) AP Matured Assets AP Acquired Assets Sunshine Group Particulars FY21 FY22 Q1 FY 23 FY21 FY22 Q1 FY23 FY21 FY22 Q1 FY23 Q1 FY23 FY21 FY22 Q1 FY23 Bed Capacity 1,200 1,200 1,200 630 630 630 12
Slide 21: Speciality Mix
SPECIALITY MIX ( Q1 FY 23) SPECIALITY MIX Mother & Others Cardiac Science Child 2% 12% Cardiac Science Others Cardiac Science 20% Organ 15% 21% 19% Transplant 1% Renal Sciences Others 6% 22% Renal Sciences Renal Sciences Gastric 9% 9% Sciences Mother & 10% Child 8% Mother & KIMS Sunshine Group Child
Slide 22: Payor & Cluster Profile
PAYOR & CLUSTER PROFILE (Q1 FY 23) PAYOR MIX CLUSTER REVENUE AP Non Mature 15.7% Aarogyasri Telangana 8.1% 73.4% Q1 FY 23 Corporate Cash AP 13.1% 54.7% Mature 10.9% Q1 FY 23 CLUSTER EBITDA* AP Non Mature Insurance 13.5% 24.1% Telangana 75.0% AP Mature 11.5% Q1 FY 23 *EBITDA before IND AS 116 and oth
Slide 23: Key Achievements in Q1 FY23
KEY ACHIEVEMENTS IN Q1 FY23 22 Private & Confidential
Slide 24: Key Achievements in Q1 FY23
KEY ACHIEVEMENTS IN Q1 FY23 23 Private & Confidential
Slide 25: Key to Our Success
KEY TO OUR SUCCESS Doctor Affordable Partnerships Quality Care Modern Medical Infra 24 Private & Confidential
Slide 26: Disciplined Growth Strategy - Growing in Adjacent Markets
KIMS HAS A DISCIPLINED GROWTH STRATEGY - STRATEGICALLY GROW IN ADJACENT MARKETS SOME OF WHICH ARE ‘NATURAL EXTENSIONS’ KIMS Plans to Grow into Markets that are Adjacent to the Current Core Markets of AP and Telangana Central & Western India (Indore, Aurangabad, Nagpur & Raipur): KIMS flagship hospit
Slide 27: Update on Expansion Plans
Update on Expansion Plans 26 Private & Confidential
Slide 28: Expansion Plans
EXPANSION PLANS Current Incremental New Approx. Approx. Timeline Units Beds Beds Departments Capex (Starting April 2021) Kondapur 200 500 All Specialities 300 Cr 36-42 months Vizag 434 50 Cancer Centre 15-20 Cr 36 months Cancer Centre / Anantapur 250 150 50-60 Cr 36-48 months Mother & Child Ongole 3
Slide 29: Profit and Loss Statement
PROFIT AND LOSS STATEMENT (RS. MILLIONS) KIMS Sunshine Consol Consol Particulars Q1 FY 23 Q1 FY 23 Q1 FY 23 Q4 FY 22 Q1 FY 22 QoQ(%) YoY(%) FY 22 FY 21 YoY(%) Operating Revenue 3,864 1,091 4,955 3,723 4,732 33.1% 4.7% 16,508 13,299 24.1% Other Income 34 19 53 82 43 -34.9% 24.8% 203 102 99.3% Total R
Slide 30: Corporate Structure
CORPORATE STRUCTURE Krishna Institute of Medical Sciences Ltd. KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole (100%) (100%) (100%) (100%) AHPL KHEPL KIMS ICON KIMS Saveera KIMS Sarvejana KIMS Hospitals Srikakulam Kondapur Vizag Anantapur Kurnool (Sunshine) Bengaluru (57.8%) (86.3%) (51.
Slide 31: Thank You
Thank You 30 Private & Confidential
Krishna Institute of Medical Sciences — Q1 FY2023 Earnings Presentation on 6ix